TABLE 1.

Correlation between GALNT4 expression and patient characteristics

Boldface values indicate p < 0.05 (t test for continuous variables and χ² test for categorical variables). HBsAg, hepatitis B surface antigen; ALT, alanine aminotransferase; AFP, α-fetoprotein; BCLC, Barcelona Clinic liver cancer staging.

Characteristic	Patients (n = 120)		GALNT4 expression		p
	Number	%	High (n = 55)	Low (n = 65)
Age (years)a	120	100.0	51.9 ± 10.8	50.6 ± 12.2	0.538
Gender					0.369
Female	17	14.2	10	7
Male	103	85.8	45	58
Liver cirrhosis					0.962
Absent	106	88.3	48	58
Present	14	11.7	7	7
Child-Pugh					0.834
A	114	95.0	52	62
B	6	5.0	3	3
HBsAg					0.835
Negative	15	12.5	6	9
Positive	105	87.5	49	56
ALT (IU)					0.399
≤40	55	45.8	28	27
>40	65	54.2	27	38
AFP (ng/ml)					0.225
≤20	38	31.7	21	17
>20	82	68.3	34	48
Tumor size (cm)					0.005
≤5	72	60.0	41	31
>5	48	40.0	14	34
Tumor number					0.342
Single	97	80.8	47	50
Multiple	23	19.2	8	15
Tumor encapsulation					0.426
Complete	64	53.3	32	32
None	56	46.7	23	33
Tumor differentiation					0.016
1 + 2	84	70.0	45	39
3 + 4	36	30.0	10	26
Vascular invasion					0.017
Absent	61	50.8	35	26
Present	59	49.2	20	39
BCLC stage					0.014
0 + A	65	54.2	37	28
B + C	55	45.8	18	37
TNM stage					0.026
I + II	71	59.2	39	32
III	49	40.8	16	33

^a The results of continuous variables are expressed as mean ± S.D.